Gilead Sciences
GILD
#106
Rank
A$261.06 B
Marketcap
A$210.54
Share price
0.17%
Change (1 day)
16.82%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): A-$3.52

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A-$3.72. In 2025 the company made an earnings per share (EPS) of A$9.80 an increase over its 2024 EPS that were of A$0.54.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$3.52-135.89%
2025A$9.801702.63%
2024A$0.54-91.65%
2023A$6.5123.98%
2022A$5.25-25.86%
2021A$7.084850%
2020A$0.14-97.64%
2019A$6.070.9%
2018A$6.0118.71%
2017A$5.07-64.88%
2016A$14.43-18.45%
2015A$17.6955.28%
2014A$11.39296.02%
2013A$2.8817.89%
2012A$2.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.50-435.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.09-129.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.11-237.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.77-1,249.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.22-723.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$8.13-318.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.74-308.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$24.80-766.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.81-148.67%๐Ÿ‡บ๐Ÿ‡ธ USA